Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer

Akun E., Okutur K., Seber S., Korkmaz T. , Aydin K., Bozkurt M., ...More

JOURNAL OF BUON, vol.17, no.4, pp.669-676, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 4
  • Publication Date: 2012
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.669-676


Purpose: To determine the clinical features of bevacizumab-associated toxicities in metastatic colorectal cancer (MCRC) patients.